Prudential Financial’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.4K | Buy |
+10,345
| New | +$95.4K | ﹤0.01% | 2291 |
|
|
2025
Q1 | – | Sell |
-10,160
| Closed | -$109K | – | 2294 |
|
|
2024
Q4 | $109K | Buy |
+10,160
| New | +$109K | ﹤0.01% | 2140 |
|
|
2022
Q4 | – | Sell |
-37,980
| Closed | -$391K | – | 2597 |
|
|
2022
Q3 | $391K | Buy |
+37,980
| New | +$391K | ﹤0.01% | 2183 |
|
|
2022
Q2 | – | Sell |
-97,780
| Closed | -$1.2M | – | 2668 |
|
|
2022
Q1 | $1.2M | Buy |
97,780
+19,900
| +26% | +$245K | ﹤0.01% | 1788 |
|
|
2021
Q4 | $1.35M | Buy |
+77,880
| New | +$1.35M | ﹤0.01% | 1734 |
|